Ignite Creation Date:
2025-12-26 @ 4:00 PM
Ignite Modification Date:
2026-02-24 @ 5:04 PM
Study NCT ID:
NCT02476006
Status:
COMPLETED
Last Update Posted:
2022-03-28
First Post:
2015-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-23
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-16
First Submit QC Date:
None
Study First Post Date:
2015-06-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-03-13
Results First Submit QC Date:
None
Results First Post Date:
2020-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-21
Last Update Post Date:
2022-03-28
Last Update Post Date Type:
ACTUAL